| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6979948
[patent_doc_number] => 20050289666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Starch-inducible promoters, recombinant gene constructs, and methods of regulating gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/122494
[patent_app_country] => US
[patent_app_date] => 2005-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7104
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0289/20050289666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11122494
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/122494 | Starch-inducible promoters, recombinant gene constructs, and methods of regulating gene expression | May 3, 2005 | Abandoned |
Array
(
[id] => 6925367
[patent_doc_number] => 20050238622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Compositions and methods for treating cancer with an oncolytic viral agent'
[patent_app_type] => utility
[patent_app_number] => 10/978278
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10307
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978278 | Compositions and methods for treating cancer with an oncolytic viral agent | Oct 27, 2004 | Abandoned |
Array
(
[id] => 11438297
[patent_doc_number] => 20170039316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'Compositions, processes and algorithms for microbial detection'
[patent_app_type] => utility
[patent_app_number] => 10/973113
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 93262
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10973113
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/973113 | Compositions, processes and algorithms for microbial detection | Oct 24, 2004 | Abandoned |
Array
(
[id] => 4915142
[patent_doc_number] => 20080095742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Composition for Treating Virus Infection Disease Comprising Jab1'
[patent_app_type] => utility
[patent_app_number] => 10/531543
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7848
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531543 | Composition for Treating Virus Infection Disease Comprising Jab1 | Aug 30, 2004 | Abandoned |
Array
(
[id] => 7036718
[patent_doc_number] => 20050034177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Genetic modification of male germ cells for generation of transgenic species & genetic therapies'
[patent_app_type] => utility
[patent_app_number] => 10/842850
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19339
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20050034177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842850 | Genetic modification of male germ cells for generation of transgenic species & genetic therapies | May 9, 2004 | Abandoned |
Array
(
[id] => 7673347
[patent_doc_number] => 20040180432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Methods, compositions and devices for growing hematopoietics cells'
[patent_app_type] => new
[patent_app_number] => 10/808276
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9023
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808276
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808276 | Methods, compositions and devices for growing hematopoietics cells | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7389845
[patent_doc_number] => 20040037814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Proliferation of hepatocyte precursors'
[patent_app_type] => new
[patent_app_number] => 10/645610
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4379
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10645610
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/645610 | Proliferation of hepatocyte precursors | Aug 21, 2003 | Abandoned |
Array
(
[id] => 7382977
[patent_doc_number] => 20040082080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Method of measuring molecular interactions'
[patent_app_type] => new
[patent_app_number] => 10/632725
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16639
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10632725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/632725 | Method of measuring molecular interactions | Jul 31, 2003 | Abandoned |
| 90/006733 | THREE-DIMENSIONAL CELL AND TISSUE CULTURE SYSTEM | Jul 30, 2003 | Issued |
| 90/006731 | THREE-DIMENSIONAL CARTILAGE CULTURES | Jul 30, 2003 | Issued |
Array
(
[id] => 6911832
[patent_doc_number] => 20050175590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Viral expression vectors'
[patent_app_type] => utility
[patent_app_number] => 10/624193
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6059
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175590.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624193 | Viral expression vectors | Jul 20, 2003 | Issued |
Array
(
[id] => 7219451
[patent_doc_number] => 20050260596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/618526
[patent_app_country] => US
[patent_app_date] => 2003-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16364
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260596.pdf
[firstpage_image] =>[orig_patent_app_number] => 10618526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/618526 | Packaging systems for human recombinant adenovirus to be used in gene therapy | Jul 10, 2003 | Abandoned |
Array
(
[id] => 612808
[patent_doc_number] => 07148205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Intravascular delivery of non-viral nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 10/600290
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14313
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600290 | Intravascular delivery of non-viral nucleic acid | Jun 19, 2003 | Issued |
Array
(
[id] => 7466514
[patent_doc_number] => 20040101962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Dedifferentiated, programmable stem cells of monocytic origin, and their production and use'
[patent_app_type] => new
[patent_app_number] => 10/372657
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15809
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101962.pdf
[firstpage_image] =>[orig_patent_app_number] => 10372657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/372657 | Dedifferentiated, programmable stem cells of monocytic origin, and their production and use | Feb 24, 2003 | Abandoned |
Array
(
[id] => 6821630
[patent_doc_number] => 20030219791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Transducer of MAS signalling'
[patent_app_type] => new
[patent_app_number] => 10/370860
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7944
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370860
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370860 | Transducer of MAS signalling | Feb 19, 2003 | Abandoned |
Array
(
[id] => 6628292
[patent_doc_number] => 20030211088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same'
[patent_app_type] => new
[patent_app_number] => 10/220205
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9026
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220205 | Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same | Feb 11, 2003 | Abandoned |
| 10/111680 | Methods and composition for enhancing developmental potential of oocytes and zygotes | Dec 2, 2002 | Abandoned |
Array
(
[id] => 6857870
[patent_doc_number] => 20030131371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Production of nuclear transfer horse embryos by piezo-driven injection of somatic cell nuclei and activation with stallion sperm cytosolic extract'
[patent_app_type] => new
[patent_app_number] => 10/304181
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5408
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20030131371.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304181
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304181 | Production of nuclear transfer horse embryos by piezo-driven injection of somatic cell nuclei and activation with stallion sperm cytosolic extract | Nov 25, 2002 | Abandoned |
Array
(
[id] => 6761306
[patent_doc_number] => 20030124668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell'
[patent_app_type] => new
[patent_app_number] => 10/263159
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19164
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124668.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263159
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263159 | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell | Oct 1, 2002 | Issued |
Array
(
[id] => 6813194
[patent_doc_number] => 20030072744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Methods of altering cardiac cell phenotype'
[patent_app_type] => new
[patent_app_number] => 10/247274
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20138
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247274 | Methods of altering cardiac cell phenotype | Sep 17, 2002 | Abandoned |
